HISLOC INJ Profile



Product

product image
HISLOC INJ
Company
Cadila Pharmaceuticals Limited
Group
Allopathic
Subgroup
Other Specialties
Main Combination
Pheniramine Maleate
Storage
Room Temparature
Type
Injection  
Packing
Packing
Mrp
Tax
30ml   
Rs 17.52   
+ inc.tax   
10ml   
Rs 7.63   
+ inc.tax   
30ML   
Rs   
+ inc.tax   
10ML   
Rs   
+ inc.tax   
Indication
Itching of unknown genesis and of various localization, eczema, dermatitis, urticaria, skinoedema, insect bits, photo-dermatitis, rhintitis, tail eczema in horses, stomatitis, toxic hoofcorns an inflammation of th hooves of cattle, serum sickness, paresis during pregnancy, puerperal toxemia and secondary retention, pulmonary oedema in cattle pulmonary emphysema in horses, toxic hypoplasia.
The usefulness of HISLOC has also been demonstrated in drug allergies, anaphylactic shock laminitis, and bloat in ruminants due to histamine atony of the rumen.  In addition, it has been demonstrated in the treatment of acute septic metritis in conjunction with antibacterial  therapy.
Composition
Each ml contains :
Pheniramine Maleate I.P.    : 22.75 mg.
Methylparaben I.P.  : 0.135 % w/v
Propylparaben I.P.   : 0.015% w/v
(As preservative)
water for injection I.P.  : q.s
.CorticosteroidDexamethasone Sodium Phosphate B.P. (Vet) - 4.4 mg.
Equivalent to Dexamethasone Phosphate - 4 mg.
Equivalent to Dexamethasone - 3.34 mg.
Methylparaben I.P. - 0.15% w/v (as preservative)
Propylparaben I.P. - 0.02% w/v (as preservative)
Water for Injection I.P. - q.s.

Dosage
Canine:
N/A
Sheep
N/A
Poultry
Small Animals : 0.5 -1 ml or more
Large Animals
5-10 ml or more
Others
N/A
Administration
HISLOC may be administred intramuscularly or intravenously.  
Advantages
N/A
Precautions
N/A
Go Back